Read More
May 24, 2017
Rare Cancers Present Unique Challenges
About 1 in 5 cancer diagnoses in the US is for a rare cancer, according to a report prepared by American Cancer Society researchers.
May 24, 2017
FDA Approves Keytruda (Pembrolizumab) for Any Tumor with Specific Genetic Change
The US Food and Drug Administration (FDA) has expanded the approval of the immunotherapy drug Keytruda (pembrolizumab) to include tumors with a specific genetic change regardless of cancer type.
May 22, 2017
Melanoma Survivor Finds Hope Through Immunotherapy
When Bryant Wieneke started feeling “funky” in April 2016, he figured it was just part of getting older. A urine test revealed abnormal cells, which led to more testing and eventually, a diagnosis of advanced melanoma skin cancer.